Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 6Recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 3Other hematologic neoplasm 2Gynecologic 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Genitourinary 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 2Mental Disorders 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1

Interventions

Paclitaxel 81Carboplatin 67pembrolizumab 62Bevacizumab 58Cisplatin 49Specimen Handling 29Drug Therapy 26Blood Specimen Collection 23olaparib 20Cyclophosphamide 18Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14Brachytherapy 14fludarabine 13Radiotherapy 13abemaciclib 12Injections 12Topotecan 11Nivolumab 11Doxorubicin 11lenvatinib 10Fulvestrant 10Fluorouracil 10Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Behavior Therapy × Gynecologic × Clear all
NCT07282158 2026-05-11

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

Fred Hutchinson Cancer Center

Phase NA Recruiting
25 enrolled
Gynecologic

Mental Disorders, Ovarian Neoplasms

NCT06855706 2026-01-06

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Roswell Park Cancer Institute

Phase NA Recruiting
120 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡